- Home
- IVVD vs BZFD Comparison
IVVD vs BZFD Comparison
Compare IVVD & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- BZFD
- Stock Information
- Founded
- IVVD 2020
- BZFD 2006
- Country
- IVVD United States
- BZFD United States
- Employees
- IVVD N/A
- BZFD N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- BZFD Movies/Entertainment
- Sector
- IVVD Health Care
- BZFD Consumer Discretionary
- Exchange
- IVVD Nasdaq
- BZFD Nasdaq
- Market Cap
- IVVD 69.0M
- BZFD 76.7M
- IPO Year
- IVVD 2021
- BZFD N/A
- Fundamental
- Price
- IVVD $0.93
- BZFD $2.15
- Analyst Decision
- IVVD Strong Buy
- BZFD
- Analyst Count
- IVVD 3
- BZFD 0
- Target Price
- IVVD $5.85
- BZFD N/A
- AVG Volume (30 Days)
- IVVD 3.1M
- BZFD 408.2K
- Earning Date
- IVVD 05-15-2025
- BZFD 05-07-2025
- Dividend Yield
- IVVD N/A
- BZFD N/A
- EPS Growth
- IVVD N/A
- BZFD N/A
- EPS
- IVVD N/A
- BZFD 0.34
- Revenue
- IVVD $36,688,000.00
- BZFD $188,899,000.00
- Revenue This Year
- IVVD $606.63
- BZFD $89.62
- Revenue Next Year
- IVVD $83.30
- BZFD $4.50
- P/E Ratio
- IVVD N/A
- BZFD $6.39
- Revenue Growth
- IVVD N/A
- BZFD N/A
- 52 Week Low
- IVVD $0.35
- BZFD $1.61
- 52 Week High
- IVVD $2.74
- BZFD $5.68
- Technical
- Relative Strength Index (RSI)
- IVVD 63.94
- BZFD 54.79
- Support Level
- IVVD $0.81
- BZFD $1.91
- Resistance Level
- IVVD $1.00
- BZFD $2.50
- Average True Range (ATR)
- IVVD 0.12
- BZFD 0.17
- MACD
- IVVD 0.02
- BZFD 0.02
- Stochastic Oscillator
- IVVD 64.76
- BZFD 49.28
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.